Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Systemic lupus erythematosus and accelerated atherosclerosis.

× No keyword cloud information.

20 in total

1. Selective cyclooxygenase-2 inhibitor suppresses renal thromboxane production but not proliferative lesions in the MRL/lpr murine model of lupus nephritis.

Authors: Jim C Oates; Perry V Halushka; Florence N Hutchison; Philip Ruiz; Gary S Gilkeson
Journal: Am J Med Sci Date: 2011-02 Impact factor: 2.378

Review 2. [The heart in rheumatic diseases].

Authors: C Specker
Journal: Internist (Berl) Date: 2007-03 Impact factor: 0.743

3. Manifestations of systemic lupus erythematosus.

Authors: Manole Cojocaru; Inimioara Mihaela Cojocaru; Isabela Silosi; Camelia Doina Vrabie
Journal: Maedica (Buchar) Date: 2011-10

Review 4. Prevalence and burden of pediatric-onset systemic lupus erythematosus.

Authors: Sylvia Kamphuis; Earl D Silverman
Journal: Nat Rev Rheumatol Date: 2010-08-03 Impact factor: 20.543

5. Novel cardiovascular risk factors and cardiac event predictors in female inactive systemic lupus erythematosus patients.

Authors: Omer Karadag; Meral Calguneri; Enver Atalar; Bunyamin Yavuz; Ali Akdogan; Umut Kalyoncu; Sule Apras Bilgen; Necla Ozer; A Ihsan Ertenli; Kenan Ovunc; Sedat Kiraz
Journal: Clin Rheumatol Date: 2006-08-15 Impact factor: 2.980

Review 6. Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases.

Authors: Cristina Panico; Gianluigi Condorelli
Journal: Clin Rev Allergy Immunol Date: 2018-12 Impact factor: 8.667

Review 7. HDAC inhibition in lupus models.

Authors: Christopher M Reilly; Nicole Regna; Nilamadhab Mishra
Journal: Mol Med Date: 2011-02-11 Impact factor: 6.354

8. Arterial distensibility in chronic inflammatory rheumatic disorders.

Authors: Mustafa Yildiz
Journal: Open Cardiovasc Med J Date: 2010-02-23

9. Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis.

Authors: Jennifer M P Woo; Zhuofeng Lin; Mohamad Navab; Casey Van Dyck; Yvette Trejo-Lopez; Krystal M T Woo; Hongyun Li; Lawrence W Castellani; Xuping Wang; Noriko Iikuni; Ornella J Rullo; Hui Wu; Antonio La Cava; Alan M Fogelman; Aldons J Lusis; Betty P Tsao
Journal: Arthritis Res Ther Date: 2010-05-18 Impact factor: 5.156

10. Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study.

Authors: A Elisabeth Hak; Elizabeth W Karlson; Diane Feskanich; Meir J Stampfer; Karen H Costenbader
Journal: Arthritis Rheum Date: 2009-10-15